Recent Blog Posts

View Post: Treatment of COPD - Guide to COPD Treatment - Medicines for COPD ...
26 Nov 2009 by Yogesh Mishra  
Tags: bronchodilators for COPD, bullectomy, COPD medications, COPD medicines, COPD patients, COPD surgery, COPD treatments, COPD vaccines, inhaled glucocorticosteroids, mild COPD, swelling in airways, treating COPD ...
View Blog: Good Evening World - http://www.goodeveningworld.com/

---

View Post: Roflumilast in COPD « NPCi blog
18 Nov 2009 by bowersc  
The primary endpoints were the change in pre-bronchodilator FEV1 during treatments and the rate of COPD exacerbations. Pooled results indicated that roflumilast produced a modest improvement in pre-bronchodilator FEV1 compared with ...
View Blog: NPCi blog - http://www.npci.org.uk/blog/

---

View Post: Regional Respiratory Medicine: Symbicort catching up with Seretide ...
22 Nov 2009 by RRM Web log  
Subjects had to have pretty severe COPD, with an FEV1 of less than 50% predicted on their initial pre-bronchodilator spirometry, although 25% ended up categorised as moderate if the GOLD - compliant definition of post-bronchodilator ...
View Blog: Regional Respiratory Medicine - http://regionalmedicine.blogspot.com/

---

View Post: Pharmacist.com
Inhaled corticosteroids: Risks outweigh benefit ...
18 Nov 2009 ...
View Blog: http://www.pharmacist.com/

---

View Post: Early Treatment off COPD May Increase Life Expectancy
31 Aug 2009
Dr. Klaus F. Rabe, of Leiden University Medical Center in the Netherlands led the second study in which Daxas was used in addition to the standard COPD treatments with long-acting bronchodilators or anticholinergics. ...
View Blog: Healthnews.com - More Natural Health

---

View Post: New analysis shows SYMBICORT® improved airflow obstruction in ...
9 Nov 2009
Additionally, the study assessed the median time to onset of bronchodilation, or opening of the airways, which was defined as the point at which >50 percent of patients achieved a >15 percent FEV1 improvement, after dosing on the day of randomization and at the end of six ... SYMBICORT 160/4.5 mcg is indicated for the maintenance treatment of airflow obstruction in patients with chronic obstructive pulmonary disease (COPD), including chronic bronchitis and emphysema. ...
View Blog: AZ US news feed - http://www.astrazeneca-us.com/

---

View Post: MedWire News - Respiratory - Responses to combined LABA–ICS ...
19 Nov 2009
To investigate, the researchers studied 165 patients with COPD who had a post-bronchodilator ratio of FEV1/forced vital capacity ratio of less than 0.7 and a smoking history of more than 10 pack-years. ...
View Blog: MedWire News - Respiratory - http://www.medwire-news.md/48/Respiratory.html

---

View Post: IngentaConnect Worldwide burden of COPD in high- and low-income ...
16 Jul 2008 by PLATINO Team,  
OBJECTIVE: To describe the burden of chronic obstructive pulmonary disease (COPD) in Latin America. DESIGN: This is a multicentre study. Post-bronchodilator spirometry was used and the main outcome measure was FEV1/FVC < 0.7 (fixed ...
View Blog: Latest Issue of The International Journal... - http://www.ingentaconnect.com/content/iuatld/ijtld...

---

View Post: Novartis says FDA wants more data on Lung Drug bronchodilator ...
19 Oct 2009 by Irina Waqar  
QAB149 was submitted for US regulatory approval in December 2008 as a new once-daily bronchodilator for maintenance treatment of airflow obstruction in patients with COPD. The original submission was based on a Phase III clinical trial ...
View Blog: CEOWORLD Magazine - http://ceoworld.biz/ceo/

---

View Post: Step-by-step: managing COPD flare-ups - KIVITV.COM
Boise. News ...
9 Nov 2009 ...
View Blog: http://www.kivitv.com/global/category.asp?c=91948

---